Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series. (Q55279558)
Jump to navigation
Jump to search
scientific article published on 16 May 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series. |
scientific article published on 16 May 2018 |
Statements
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series. (English)
1 reference
Lillian Sun
1 reference
Pauline Funchain
1 reference
Jung Min Song
1 reference
Patricia Rayman
1 reference
Charles Tannenbaum
1 reference
Jennifer Ko
1 reference
Michael Mcnamara
1 reference
C Marcela Diaz-Montero
1 reference
Brian Gastman
1 reference
16 May 2018
1 reference
6
1 reference
1
1 reference
36
1 reference
1 reference
Identifiers
1 reference